According to a recent International Foundation survey report, health care costs are expected to increase by 7% between 2022 and 2021. This increase is driven by a number of factors,… Read more >
January 12, 2023 Communication, Employee Benefits, Employee Benefits Survey, Prescription Drugs Read more >
A healthy reset has been a standard theme entering the new year, but it shouldn’t be the only time of year workplace wellness gets prioritized. What an individual’s weight says… Read more >
January 5, 2023 Employee Benefits, Employee Benefits Survey, Prescription Drugs, Wellness Read more >
Late last year, Congress passed the Consolidated Appropriations Act, 2021 (CAA), which contained a provision requiring health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. RxDC… Read more >
December 7, 2022 Employee Benefits, Health Care, Insurance, Legislative, Prescription Drugs, Regulatory, U.S. Read more >
President Joe Biden is expected to sign a medical marijuana research bill that could eventually have an impact on health plan coverage of medical marijuana. On November 16, the U.S…. Read more >
December 1, 2022 Communication, Compliance, Employee Benefits, Health Care, Insurance, Legislative, Prescription Drugs, U.S. Read more >
RxDC Overview In late 2021, Congress passed the Consolidated Appropriations Act, 2021 (CAA) which contained a provision that requires health care plans to submit Prescription Drug Data Collection (RxDC) reports… Read more >
November 4, 2022 Compliance, Employee Benefits, Health Care, Insurance, Prescription Drugs, U.S. Read more >
Despite major advancements in technology and medication over the last four decades, people with diabetes still face barriers to getting the best care, a panel of experts said during an… Read more >
August 9, 2022 Compliance, Disease Management, Employee Benefits, Health Care, Human Resources (HR), Prescription Drugs, U.S. Read more >
On December 27, 2020, the Consolidated Appropriations Act (CAA) of 2021 was signed into law and included the No Surprises Act (the Act). With so much guidance already published addressing… Read more >
January 25, 2022 Communication, DOL, Employee Benefits, Health Care, Insurance, Legislative, Prescription Drugs Read more >
Benefits practitioners have grown accustomed to headlines addressing the escalating costs of prescription drug spending. Despite concerted efforts, the cost of commonly prescribed brand-name drugs continues to grow at alarming… Read more >
June 8, 2021 Employee Benefits, Employee Benefits Survey, Health Care, Prescription Drugs, U.S. Read more >
The COVID-19 pandemic has had significant implications for workplaces across the world, and employers and workers have needed to make difficult decisions regarding retirement, health and paid leave benefits. A new… Read more >
May 4, 2021 Canada, Coronavirus (COVID-19), Defined Benefit (DB) Plans, Defined Contribution (DC) Plans, Employee Assistance Program (EAP), Employee Benefits, Mental Health, Prescription Drugs, Retirement Read more >
Health care benefits remain a critical part of the relationship between employers and workers, especially during these times of rapid change and uncertainty. In addition to serving as an important… Read more >
March 31, 2021 Employee Benefits, Employee Benefits Survey, Health Care, Human Resources (HR), Mental Health, Prescription Drugs, U.S., Wellness Read more >